minimal Common Oncology Data Elements (mCODE) Implementation Guide
4.0.0-ballot - STU4 Ballot
minimal Common Oncology Data Elements (mCODE) Implementation Guide
4.0.0-ballot - STU4 Ballot
minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International / Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 4.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions
| Active as of 2024-04-09 | Maturity Level: 4 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="mcode-cancer-stage-type-vs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="http://snomed.info/id/399566009">399566009</a></td><td>Tumor-node-metastasis (TNM) category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/78873005">78873005</a></td><td>T category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/277206009">277206009</a></td><td>N category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/277208005">277208005</a></td><td>M category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399703000">399703000</a></td><td>Integrated TNM category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399437009">399437009</a></td><td>Integrated M category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399458003">399458003</a></td><td>Integrated N category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399556001">399556001</a></td><td>Integrated T category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/106248000">106248000</a></td><td>TNM classification of malignant tumor before any treatment (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399387003">399387003</a></td><td>cM category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399534004">399534004</a></td><td>cN category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399504009">399504009</a></td><td>cT category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/106249008">106249008</a></td><td>TNM classification of malignant tumor after operation (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/371497001">371497001</a></td><td>pM category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/371494008">371494008</a></td><td>pN category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/384625004">384625004</a></td><td>pT category (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399390009">399390009</a></td><td>Tumor-node-metastasis (TNM) stage grouping (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399537006">399537006</a></td><td>Clinical TNM stage grouping (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/399588009">399588009</a></td><td>Pathologic TNM stage grouping (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385361009">385361009</a></td><td>International Federation of Gynecology and Obstetrics stage for gynecological malignancy (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385363007">385363007</a></td><td>International Federation of Gynecology and Obstetrics ovarian tumor stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385365000">385365000</a></td><td>International Federation of Gynecology and Obstetrics stage for epithelial tumor of ovary (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385367008">385367008</a></td><td>International Federation of Gynecology and Obstetrics stage for cervical carcinoma (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385375002">385375002</a></td><td>International Federation of Gynecology and Obstetrics stage for endometrial carcinoma (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385369006">385369006</a></td><td>International Federation of Gynecology and Obstetrics stage for vulvar melanoma (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385373009">385373009</a></td><td>International Federation of Gynecology and Obstetrics uterine tumor stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385388004">385388004</a></td><td>Lymphoma stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385349001">385349001</a></td><td>Clinical stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/103420007">103420007</a></td><td>Modified Dukes stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385357003">385357003</a></td><td>Dukes stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/17964000">17964000</a></td><td>Residual tumor stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/371495009">371495009</a></td><td>Stage of tumor involvement of non-regional lymph nodes (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/409720004">409720004</a></td><td>International neuroblastoma staging system stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/405931009">405931009</a></td><td>National Wilms Tumor Study Group Stage (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/405916000">405916000</a></td><td>Intergroup rhabdomyosarcoma study post-surgical clinical group (observable entity)</td></tr><tr><td><a href="http://snomed.info/id/385377005">385377005</a></td><td>Gleason grade finding for prostatic cancer (finding)</td></tr></table></li><li>Include these codes as defined in <a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-nciThesaurus.html"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C134969</td><td>AIDS-Related Kaposi Sarcoma Stage</td></tr><tr><td>C90529</td><td>AJCC v6 Stage</td></tr><tr><td>C90530</td><td>AJCC v7 Stage</td></tr><tr><td>C177555</td><td>AJCC v8 Clinical Stage</td></tr><tr><td>C177556</td><td>AJCC v8 Pathologic Stage</td></tr><tr><td>C132248</td><td>AJCC v8 Stage</td></tr><tr><td>C180901</td><td>AJCC v9 Stage</td></tr><tr><td>C177558</td><td>Ann Arbor Clinical Stage</td></tr><tr><td>C177559</td><td>Ann Arbor Pathologic Stage</td></tr><tr><td>C141138</td><td>Ann Arbor Stage</td></tr><tr><td>C115134</td><td>BCLC Stage</td></tr><tr><td>C141212</td><td>Binet Stage</td></tr><tr><td>C139445</td><td>Breast Cancer Anatomic Stage</td></tr><tr><td>C139446</td><td>Breast Cancer Prognostic Stage</td></tr><tr><td>C139006</td><td>Durie/Salmon Stage</td></tr><tr><td>C141099</td><td>ENSAT Stage</td></tr><tr><td>C186618</td><td>FIGO 2009 Stage</td></tr><tr><td>C186617</td><td>FIGO 2018 Stage</td></tr><tr><td>C157232</td><td>FIGO/TNM Stage</td></tr><tr><td>C28067</td><td>Hepatoblastoma Stage</td></tr><tr><td>C139007</td><td>International Staging System Stage</td></tr><tr><td>C141147</td><td>Lugano Stage</td></tr><tr><td>C143151</td><td>Masaoka-Koga Stage</td></tr><tr><td>C146847</td><td>Mediastinal Malignant Germ Cell Tumor Stage</td></tr><tr><td>C16899</td><td>Neoplasm Stage</td></tr><tr><td>C174125</td><td>Neoplastic Disease Extent Indicator</td></tr><tr><td>C141461</td><td>Occult Stage</td></tr><tr><td>C133427</td><td>International Neuroblastoma Risk Group Staging System</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="4"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="cic"/>
</extension>
<url
value="http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-stage-type-vs"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.40.15.48.19"/>
</identifier>
<version value="4.0.0-ballot"/>
<name value="CancerStageTypeVS"/>
<title value="Cancer Stage Type Value Set"/>
<status value="active"/>
<experimental value="false"/>
<date value="2024-04-09T21:21:25+00:00"/>
<publisher value="HL7 International / Clinical Interoperability Council"/>
<contact>
<name value="HL7 International / Clinical Interoperability Council"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/cic"/>
</telecom>
<telecom>
<system value="email"/>
<value value="ciclist@lists.HL7.org"/>
</telecom>
</contact>
<description
value="Codes that identify the kind of stage reported in an Observation, necessary to correctly interpret the value associated with a staging Observation. In terms of the SNOMED CT hierarchy, these codes represent observable entities. If the staging system used to determine the stage is not implicit in this code, the staging system must be separately recorded in Observation.method. More specific staging profiles, if available, should be consulted before determining the correct code."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="US"/>
<display value="United States of America"/>
</coding>
</jurisdiction>
<copyright
value="This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement"/>
<compose>
<include>
<system value="http://snomed.info/sct"/>
<concept>
<code value="399566009"/>
<display
value="Tumor-node-metastasis (TNM) category (observable entity)"/>
</concept>
<concept>
<code value="78873005"/>
<display value="T category (observable entity)"/>
</concept>
<concept>
<code value="277206009"/>
<display value="N category (observable entity)"/>
</concept>
<concept>
<code value="277208005"/>
<display value="M category (observable entity)"/>
</concept>
<concept>
<code value="399703000"/>
<display value="Integrated TNM category (observable entity)"/>
</concept>
<concept>
<code value="399437009"/>
<display value="Integrated M category (observable entity)"/>
</concept>
<concept>
<code value="399458003"/>
<display value="Integrated N category (observable entity)"/>
</concept>
<concept>
<code value="399556001"/>
<display value="Integrated T category (observable entity)"/>
</concept>
<concept>
<code value="106248000"/>
<display
value="TNM classification of malignant tumor before any treatment (observable entity)"/>
</concept>
<concept>
<code value="399387003"/>
<display value="cM category (observable entity)"/>
</concept>
<concept>
<code value="399534004"/>
<display value="cN category (observable entity)"/>
</concept>
<concept>
<code value="399504009"/>
<display value="cT category (observable entity)"/>
</concept>
<concept>
<code value="106249008"/>
<display
value="TNM classification of malignant tumor after operation (observable entity)"/>
</concept>
<concept>
<code value="371497001"/>
<display value="pM category (observable entity)"/>
</concept>
<concept>
<code value="371494008"/>
<display value="pN category (observable entity)"/>
</concept>
<concept>
<code value="384625004"/>
<display value="pT category (observable entity)"/>
</concept>
<concept>
<code value="399390009"/>
<display
value="Tumor-node-metastasis (TNM) stage grouping (observable entity)"/>
</concept>
<concept>
<code value="399537006"/>
<display value="Clinical TNM stage grouping (observable entity)"/>
</concept>
<concept>
<code value="399588009"/>
<display value="Pathologic TNM stage grouping (observable entity)"/>
</concept>
<concept>
<code value="385361009"/>
<display
value="International Federation of Gynecology and Obstetrics stage for gynecological malignancy (observable entity)"/>
</concept>
<concept>
<code value="385363007"/>
<display
value="International Federation of Gynecology and Obstetrics ovarian tumor stage (observable entity)"/>
</concept>
<concept>
<code value="385365000"/>
<display
value="International Federation of Gynecology and Obstetrics stage for epithelial tumor of ovary (observable entity)"/>
</concept>
<concept>
<code value="385367008"/>
<display
value="International Federation of Gynecology and Obstetrics stage for cervical carcinoma (observable entity)"/>
</concept>
<concept>
<code value="385375002"/>
<display
value="International Federation of Gynecology and Obstetrics stage for endometrial carcinoma (observable entity)"/>
</concept>
<concept>
<code value="385369006"/>
<display
value="International Federation of Gynecology and Obstetrics stage for vulvar melanoma (observable entity)"/>
</concept>
<concept>
<code value="385373009"/>
<display
value="International Federation of Gynecology and Obstetrics uterine tumor stage (observable entity)"/>
</concept>
<concept>
<code value="385388004"/>
<display value="Lymphoma stage (observable entity)"/>
</concept>
<concept>
<code value="385349001"/>
<display value="Clinical stage (observable entity)"/>
</concept>
<concept>
<code value="103420007"/>
<display value="Modified Dukes stage (observable entity)"/>
</concept>
<concept>
<code value="385357003"/>
<display value="Dukes stage (observable entity)"/>
</concept>
<concept>
<code value="17964000"/>
<display value="Residual tumor stage (observable entity)"/>
</concept>
<concept>
<code value="371495009"/>
<display
value="Stage of tumor involvement of non-regional lymph nodes (observable entity)"/>
</concept>
<concept>
<code value="409720004"/>
<display
value="International neuroblastoma staging system stage (observable entity)"/>
</concept>
<concept>
<code value="405931009"/>
<display
value="National Wilms Tumor Study Group Stage (observable entity)"/>
</concept>
<concept>
<code value="405916000"/>
<display
value="Intergroup rhabdomyosarcoma study post-surgical clinical group (observable entity)"/>
</concept>
<concept>
<code value="385377005"/>
<display
value="Gleason grade finding for prostatic cancer (finding)"/>
</concept>
</include>
<include>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<concept>
<code value="C134969"/>
<display value="AIDS-Related Kaposi Sarcoma Stage"/>
</concept>
<concept>
<code value="C90529"/>
<display value="AJCC v6 Stage"/>
</concept>
<concept>
<code value="C90530"/>
<display value="AJCC v7 Stage"/>
</concept>
<concept>
<code value="C177555"/>
<display value="AJCC v8 Clinical Stage"/>
</concept>
<concept>
<code value="C177556"/>
<display value="AJCC v8 Pathologic Stage"/>
</concept>
<concept>
<code value="C132248"/>
<display value="AJCC v8 Stage"/>
</concept>
<concept>
<code value="C180901"/>
<display value="AJCC v9 Stage"/>
</concept>
<concept>
<code value="C177558"/>
<display value="Ann Arbor Clinical Stage"/>
</concept>
<concept>
<code value="C177559"/>
<display value="Ann Arbor Pathologic Stage"/>
</concept>
<concept>
<code value="C141138"/>
<display value="Ann Arbor Stage"/>
</concept>
<concept>
<code value="C115134"/>
<display value="BCLC Stage"/>
</concept>
<concept>
<code value="C141212"/>
<display value="Binet Stage"/>
</concept>
<concept>
<code value="C139445"/>
<display value="Breast Cancer Anatomic Stage"/>
</concept>
<concept>
<code value="C139446"/>
<display value="Breast Cancer Prognostic Stage"/>
</concept>
<concept>
<code value="C139006"/>
<display value="Durie/Salmon Stage"/>
</concept>
<concept>
<code value="C141099"/>
<display value="ENSAT Stage"/>
</concept>
<concept>
<code value="C186618"/>
<display value="FIGO 2009 Stage"/>
</concept>
<concept>
<code value="C186617"/>
<display value="FIGO 2018 Stage"/>
</concept>
<concept>
<code value="C157232"/>
<display value="FIGO/TNM Stage"/>
</concept>
<concept>
<code value="C28067"/>
<display value="Hepatoblastoma Stage"/>
</concept>
<concept>
<code value="C139007"/>
<display value="International Staging System Stage"/>
</concept>
<concept>
<code value="C141147"/>
<display value="Lugano Stage"/>
</concept>
<concept>
<code value="C143151"/>
<display value="Masaoka-Koga Stage"/>
</concept>
<concept>
<code value="C146847"/>
<display value="Mediastinal Malignant Germ Cell Tumor Stage"/>
</concept>
<concept>
<code value="C16899"/>
<display value="Neoplasm Stage"/>
</concept>
<concept>
<code value="C174125"/>
<display value="Neoplastic Disease Extent Indicator"/>
</concept>
<concept>
<code value="C141461"/>
<display value="Occult Stage"/>
</concept>
<concept>
<code value="C133427"/>
<display
value="International Neuroblastoma Risk Group Staging System"/>
</concept>
</include>
</compose>
</ValueSet>
IG © 2019+ HL7 International / Clinical Interoperability Council. Package hl7.fhir.us.mcode#4.0.0-ballot based on FHIR 4.0.1. Generated 2024-04-09
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change